O. S. BETTER; H. J. GURLAND; G. BRUNNER; E. HOFFER; T. M. S. CHANG; K. MAEDA; J. M. COURTNEY; R. MAINI; P. C. FARRELL; J. L. ROSENBAUM; M. C. GELFAND; S. SIDEMAN; A. GIMSON; U. TAITLEMAN; J. F. WINCHESTER
To the editor: The following summary prepared by participants in the recent International Workshop on Hemoperfusion held in Haifa, Israel, is submitted in response to the report by Lorch and Garella that appeared in the August 1979, issue (1).
Conservative medical management with support of vital systems represents the treatment of choice for most patients with toxic ingestions. For patients with serious intoxications fulfilling the following criteria, charcoal or resin hemoperfusion is indicated:  severe clinical intoxication leading to hypoventilation, hypothermia, hypotension, and nonresponsiveness despite supportive clinical measures;  lethal blood concentration of one or more potentially adsorbable drugs; and
O. S. BETTER, H. J. GURLAND, G. BRUNNER, E. HOFFER, T. M. S. CHANG, K. MAEDA, et al. Controlled Trials of Hemoperfusion for Intoxication. Ann Intern Med. 1979;91:925. doi: 10.7326/0003-4819-91-6-925_2
Download citation file:
Published: Ann Intern Med. 1979;91(6):925.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use